|
Mechanismfactor Xa inhibitors |
Active Org.- |
|
Active Indication- |
|
Drug Highest PhaseWithdrawn |
First Approval Ctry. / Loc.US |
First Approval Date23 Jun 2017 |
100 Clinical Results associated with Portola Pharma UK Ltd.
0 Patents (Medical) associated with Portola Pharma UK Ltd.
100 Deals associated with Portola Pharma UK Ltd.
100 Translational Medicine associated with Portola Pharma UK Ltd.